Detection of respiratory syncytial virus in nasal secretions from infants by enzyme-linked immunosorbent assay.

PubWeight™: 3.49‹?› | Rank: Top 1%

🔗 View Article (PMID 374650)

Published in J Infect Dis on April 01, 1979

Authors

R K Chao, M Fishaut, J D Schwartzman, K McIntosh

Articles citing this

Detection of respiratory syncytial, parainfluenza type 2, and adenovirus antigens by radioimmunoassay and enzyme immunoassay on nasopharyngeal specimens from children with acute respiratory disease. J Clin Microbiol (1981) 3.67

Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: application to clinical samples. J Clin Microbiol (1982) 3.22

Analysis of nonspecific reactions in enzyme-linked immunosorbent assay testing for human rotavirus. J Clin Microbiol (1979) 2.70

Rapid viral diagnosis of acute respiratory infections: comparison of enzyme-linked immunosorbent assay and the immunofluorescence technique for detection of viral antigens in nasopharyngeal secretions. J Clin Microbiol (1985) 2.69

Comparison of directigen RSV with viral isolation and direct immunofluorescence for the identification of respiratory syncytial virus. J Clin Microbiol (1990) 2.15

Rapid detection of respiratory syncytial virus in nasopharyngeal secretions by enzyme-linked immunosorbent assay. J Clin Microbiol (1985) 2.10

Comparison of virus culturing and immunofluorescence for rapid detection of respiratory syncytial virus in nasopharyngeal secretions: sensitivity and specificity. J Clin Microbiol (1982) 2.05

Detection of respiratory syncytial virus in nasopharyngeal secretions by inhibition of enzyme-linked immunosorbent assay. J Clin Microbiol (1981) 2.03

Evaluation of five methods for respiratory syncytial virus detection. J Clin Microbiol (1990) 2.01

Detection, pathogenesis, and therapy of respiratory syncytial virus infections. Clin Microbiol Rev (1988) 1.92

Detection of respiratory syncytial virus in clinical specimens by viral culture, direct and indirect immunofluorescence, and enzyme immunoassay. J Clin Microbiol (1988) 1.88

Enzyme immunoassay for direct detection of influenza type A and adenovirus antigens in clinical specimens. J Clin Microbiol (1982) 1.71

Rapid detection of respiratory syncytial virus in nasopharyngeal aspirates by a commercial enzyme immunoassay. J Clin Microbiol (1986) 1.67

Comparison of two new tests for rapid diagnosis of respiratory syncytial virus infections by enzyme-linked immunosorbent assay and immunofluorescence techniques. J Clin Microbiol (1986) 1.61

Comparison of enzyme-linked immunosorbent assay, indirect immunofluorescence assay, and virus isolation for detection of respiratory viruses in nasopharyngeal secretions. J Clin Microbiol (1991) 1.52

Comparison of washed nasopharyngeal cells and whole nasal secretions for detection of respiratory syncytial virus antigens by enzyme-linked immunosorbent assay. J Clin Microbiol (1986) 1.28

Time-resolved fluoroimmunoassay compared with virus isolation for rapid detection of respiratory syncytial virus in nasopharyngeal aspirates. J Clin Microbiol (1988) 1.23

Diagnostic efficacy of two rapid tests for detection of respiratory syncytial virus antigen. J Clin Microbiol (1987) 1.21

Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: development and description. J Clin Microbiol (1982) 1.20

Pertussis: the disease and new diagnostic methods. Clin Microbiol Rev (1988) 1.16

Comparison of three rapid diagnostic techniques for detection of respiratory syncytial virus from nasal wash specimens. J Clin Microbiol (1987) 1.16

Rapid immunoperoxidase assay for detection of respiratory syncytial virus in nasopharyngeal secretions. J Clin Microbiol (1983) 1.07

Mixed viral infections: detection and management. Clin Microbiol Rev (1994) 1.05

Use of nasal and pharyngeal swabs for rapid detection of respiratory syncytial virus and adenovirus antigens by enzyme-linked immunosorbent assay. J Clin Microbiol (1989) 0.95

Ag nanorod based surface-enhanced Raman spectroscopy applied to bioanalytical sensing. J Biophotonics (2012) 0.95

Detection of viral antigens, particles, and early antibodies in diagnosis. Yale J Biol Med (1985) 0.88

Enzyme-linked immunosorbent assay for detection of capsular antibodies against Haemophilus influenzae type b: comparison with radioimmunoassay. J Clin Microbiol (1983) 0.88

Rapid diagnostic methods for influenza virus in clinical specimens: a comparative study. Yale J Biol Med (1983) 0.86

Evaluation of the Becton Dickinson Directigen test for respiratory syncytial virus in nasopharyngeal aspirates. J Clin Microbiol (1990) 0.84

Capture-ELISA for serum IgM antibody to respiratory syncytial virus. J Hyg (Lond) (1986) 0.80

Enzyme immunoassays for the detection of microbial antigens and prospects for improved assays. Yale J Biol Med (1986) 0.79

Enzyme immunoassay for the detection of group A streptococcal antigen. J Clin Microbiol (1984) 0.79

Articles by these authors

Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet (1978) 10.25

Evolution and transmission of stable CTL escape mutations in HIV infection. Nature (2001) 6.57

Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med (2010) 6.38

Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis (1985) 5.91

The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr (1973) 4.22

A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med (2000) 4.14

Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature (1989) 3.54

Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J Virol (2004) 3.54

Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A (1967) 3.47

Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: application to clinical samples. J Clin Microbiol (1982) 3.22

IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity (2000) 2.58

Coronavirus infection in acute lower respiratory tract disease of infants. J Infect Dis (1974) 2.55

Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (1999) 2.51

The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis (1978) 2.32

Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med (2000) 2.31

Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks. J Infect Dis (1986) 2.26

Viral and bacterial infections in adults with chronic asthma. Am Rev Respir Dis (1979) 2.25

Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. Circulation (1998) 2.23

Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J Virol (1993) 2.21

Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team. JAMA (2000) 2.14

A comparative study of virus isolation, polymerase chain reaction, and antigen detection in children of mothers infected with human immunodeficiency virus. J Pediatr (1990) 2.09

Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J Pediatr (1980) 2.07

Coronaviridae: second report. Intervirology (1978) 2.05

Changing the needle when inoculating blood cultures. A no-benefit and high-risk procedure. JAMA (1990) 2.04

Apnea associated with respiratory syncytial virus infection in young infants. J Pediatr (1977) 2.00

Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine. N Engl J Med (1992) 1.92

Chlamydial infection of mothers and their infants. J Pediatr (1979) 1.89

The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics (1980) 1.89

Summary of a workshop on new and useful methods in viral diagnosis. J Infect Dis (1978) 1.87

Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (2000) 1.87

Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay. J Virol (2000) 1.84

Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease. Proc Natl Acad Sci U S A (1967) 1.82

Role of infection in chronic bronchitis. Am Rev Respir Dis (1976) 1.81

A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc Natl Acad Sci U S A (1997) 1.80

Early detection of human immunodeficiency virus on dried blood spot specimens: sensitivity across serial specimens. Women and Infants Transmission Study Group. J Pediatr (1996) 1.79

Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J Virol (2000) 1.79

Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection. Infect Immun (1979) 1.70

Seroepidemiologic studies of coronavirus infection in adults and children. Am J Epidemiol (1970) 1.66

Neonatal Haemophilus influenzae infection. Report of eight cases and review of the literature. Am J Dis Child (1975) 1.65

Cardiac morbidity and related mortality in children with HIV infection. JAMA (1993) 1.65

Bending-related faulting and mantle serpentinization at the Middle America trench. Nature (2003) 1.64

Interferon in nasal secretions from infants with viral respiratory tract infections. J Pediatr (1978) 1.61

Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol (1998) 1.58

Is it time to give influenza vaccine to healthy infants? N Engl J Med (2000) 1.58

A Toxoplasma gondii rhoptry protein associated with host cell penetration has unusual charge asymmetry. Mol Biochem Parasitol (1992) 1.57

Coronaviridae. Intervirology (1975) 1.55

Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis (1988) 1.52

Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus. Prog Med Virol (1980) 1.51

Morphogenesis of avian infectious bronchitis virus and a related human virus (strain 229E). J Virol (1967) 1.49

The preparation and properties of adenovirus cores. J Gen Virol (1971) 1.49

Antigenic relationships among the coronaviruses of man and between human and animal coronaviruses. J Immunol (1969) 1.48

Perineal group A streptococcal disease in a pediatric practice. Pediatrics (2000) 1.46

Isolation from man of "avian infectious bronchitis virus-like" viruses (coronaviruses) similar to 229E virus, with some epidemiological observations. J Infect Dis (1969) 1.41

Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies. Lancet (1990) 1.41

Evaluation of human and simian immunodeficiency virus plaque and neutralization assays. J Gen Virol (1989) 1.39

Inhibition of Toxoplasma gondii replication by dinitroaniline herbicides. Exp Parasitol (1996) 1.39

Altered histopathology in protein-deprived mice during Sendai virus pneumonia: evidence for delayed inflammatory response and recovery. J Infect Dis (1992) 1.39

Prevalence of respiratory syncytial virus subgroups over six consecutive outbreaks: 1981-1987. J Infect Dis (1989) 1.39

Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children. J Virol (2003) 1.38

Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol. Am J Dis Child (1984) 1.38

A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol (1999) 1.38

Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation. Immunol Lett (2001) 1.37

Localization of a Toxoplasma gondii rhoptry protein by immunoelectron microscopy during and after host cell penetration. J Protozool (1992) 1.34

Multicenter study of strains of respiratory syncytial virus. J Infect Dis (1991) 1.34

Comparison of cynomolgus and rhesus monkey kidney cells for recovery of viruses from clinical specimens. J Clin Microbiol (1979) 1.33

Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. Am J Cardiol (1989) 1.33

Alterations in cardiac and pulmonary function in pediatric rapid human immunodeficiency virus type 1 disease progressors. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Study Group. Pediatrics (2000) 1.31

CD8+ CTLs are essential for protective immunity against Encephalitozoon cuniculi infection. J Immunol (1999) 1.31

Neospora caninum: role for immune cytokines in host immunity. Exp Parasitol (1997) 1.29

Cryptogenic epilepsy: an infectious etiology? Epilepsia (2001) 1.29

Comparison of washed nasopharyngeal cells and whole nasal secretions for detection of respiratory syncytial virus antigens by enzyme-linked immunosorbent assay. J Clin Microbiol (1986) 1.28

Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. J Infect Dis (1992) 1.27

Toxoplasma gondii: purine synthesis and salvage in mutant host cells and parasites. Exp Parasitol (1982) 1.27

Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus. J Virol (1988) 1.26

Murine ileitis after intracellular parasite infection is controlled by TGF-beta-producing intraepithelial lymphocytes. Gastroenterology (2001) 1.24

A novel class of unconventional myosins from Toxoplasma gondii. J Mol Biol (1997) 1.24

Evaluation of a commercially available direct immunofluorescent staining reagent for the detection of respiratory syncytial virus in respiratory secretions. J Clin Microbiol (1986) 1.23

The association of rhinoviruses with lower respiratory tract disease in hospitalized patients. J Med Virol (1986) 1.23

Growth and body composition in children infected with the human immunodeficiency virus-1. Am J Clin Nutr (1993) 1.22

Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: development and description. J Clin Microbiol (1982) 1.20

A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group. N Engl J Med (1991) 1.20

The role of phospholipase in host cell penetration by Toxoplasma gondii. Am J Trop Med Hyg (1989) 1.20

Mice lacking the chemokine receptor CCR1 show increased susceptibility to Toxoplasma gondii infection. J Immunol (2001) 1.19

Inhibition of a penetration-enhancing factor of Toxoplasma gondii by monoclonal antibodies specific for rhoptries. Infect Immun (1986) 1.17

Toxoplasma gondii: dithiol-induced Ca2+ flux causes egress of parasites from the parasitophorous vacuole. Exp Parasitol (1997) 1.17

Monoclonal antibodies for the rapid diagnosis of respiratory syncytial virus infection by immunofluorescence. Diagn Microbiol Infect Dis (1984) 1.16

The prenatal exclusion test for Huntington's disease: experience in the west of Scotland, 1986-1993. J Med Genet (1995) 1.16

Summary of a workshop on new and useful methods in rapid viral diagnosis. J Infect Dis (1984) 1.13

Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells. J Gen Virol (1987) 1.13

A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery. J Pediatr (1984) 1.12

Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. Am J Cardiol (1990) 1.12

Secretory immunological response in infants and children to parainfluenza virus types 1 and 2. Infect Immun (1980) 1.12

Type A2 influenza viral infections in children. Am J Dis Child (1978) 1.12

The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. Pediatrics (2001) 1.10

Characterization of a novel respiratory syncytial virus-specific human cytotoxic T-lymphocyte epitope. J Virol (2000) 1.09

Isolation of Chlamydia trachomatis from infant lung tissue. N Engl J Med (1977) 1.09

Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group. J Allergy Clin Immunol (2000) 1.09